Corline Biomedical AB (ST:CLBIO) — Stock Price

Skr17.85 SEK
▼ -3.25% today

Corline Biomedical AB (ST:CLBIO) is currently trading at Skr17.85 SEK, down 3.25% today. Over the past 52 weeks, shares have ranged between Skr11.80 and Skr21.20. This page tracks Corline Biomedical AB's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see CLBIO stock market capitalisation.

Corline Biomedical AB (CLBIO) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Corline Biomedical AB's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.

Corline Biomedical AB Income Statement — Revenue, Profit & Earnings by Year

Corline Biomedical AB's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Skr7.65 Million Skr9.78 Million Skr25.03 Million Skr23.55 Million Skr7.06 Million
Cost of Revenue Skr21.86 Million Skr-3.67 Million Skr-3.35 Million Skr824.00K Skr-2.04 Million
Gross Profit Skr-14.21 Million Skr13.44 Million Skr28.38 Million Skr22.73 Million Skr9.10 Million
Research & Development
SG&A Skr13.19 Million Skr14.43 Million Skr14.50 Million Skr11.32 Million Skr9.04 Million
Total Operating Expenses Skr22.40 Million Skr36.61 Million Skr30.17 Million Skr20.40 Million Skr11.13 Million
Operating Income Skr-14.21 Million Skr-23.17 Million Skr-1.79 Million Skr2.33 Million Skr-6.91 Million
EBITDA Skr-14.12 Million Skr-23.07 Million Skr-1.69 Million Skr2.38 Million Skr-6.88 Million
EBIT Skr-14.21 Million Skr-23.16 Million Skr-1.78 Million Skr2.33 Million Skr-6.91 Million
Interest Expense Skr1.00K Skr32.00K Skr26.00K Skr0.00 Skr13.00K
Income Before Tax Skr-14.71 Million Skr-23.19 Million Skr-1.81 Million Skr2.33 Million Skr-6.92 Million
Income Tax Expense Skr-1.78 Million Skr549.00K Skr-6.00K
Net Income Skr-14.71 Million Skr-23.19 Million Skr-1.81 Million Skr2.33 Million Skr-6.92 Million

Corline Biomedical AB Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Corline Biomedical AB's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Skr98.58 Million Skr94.76 Million Skr100.11 Million Skr101.78 Million Skr101.66 Million
Total Current Assets Skr23.98 Million Skr21.04 Million Skr23.80 Million Skr36.00 Million Skr44.82 Million
Cash & Equivalents Skr20.56 Million Skr17.67 Million Skr17.01 Million Skr26.21 Million Skr41.63 Million
Short-term Investments
Net Receivables Skr2.31 Million Skr2.63 Million Skr6.79 Million Skr9.79 Million Skr3.18 Million
Inventory Skr-3.86 Million Skr1.00 Skr-889.00K
Property, Plant & Equipment Skr162.00K Skr219.00K Skr314.00K Skr280.00K Skr182.00K
Goodwill
Total Liabilities Skr4.82 Million Skr7.85 Million Skr6.79 Million Skr7.19 Million Skr9.43 Million
Total Current Liabilities Skr4.82 Million Skr7.85 Million Skr6.79 Million Skr7.19 Million Skr9.43 Million
Long-term Debt
Net Debt Skr-20.56 Million Skr-17.67 Million Skr-17.01 Million Skr-26.21 Million Skr-41.63 Million
Total Stockholder Equity Skr93.76 Million Skr86.91 Million Skr93.32 Million Skr94.59 Million Skr92.23 Million
Retained Earnings Skr-163.77 Million Skr-148.12 Million Skr-127.64 Million Skr2.33 Million Skr-6.92 Million

Corline Biomedical AB Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Corline Biomedical AB generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Skr-17.69 Million Skr-8.64 Million Skr886.00K Skr-6.45 Million Skr-4.83 Million
Capital Expenditures Skr47.00K Skr7.50 Million Skr10.62 Million Skr9.00 Million Skr9.62 Million
Free Cash Flow Skr-17.74 Million Skr-16.14 Million Skr-9.73 Million Skr-15.45 Million Skr-14.45 Million
Investing Cash Flow Skr-982.00K Skr-7.50 Million Skr-10.62 Million Skr-9.00 Million Skr-9.56 Million
Financing Cash Flow Skr21.56 Million Skr16.79 Million Skr537.00K Skr26.00K Skr47.13 Million
Dividends Paid
Stock-Based Compensation
Depreciation Skr84.00K Skr95.00K Skr97.00K Skr56.00K Skr31.00K
Change in Cash Skr2.89 Million Skr656.00K Skr-9.20 Million Skr-15.43 Million Skr32.73 Million

Corline Biomedical AB Earnings History — EPS Actual vs. Analyst Estimates

Track Corline Biomedical AB's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 06, 2026
Feb 16, 2026 -0.20
Sep 30, 2025 -0.14
Aug 26, 2025 -0.13
May 08, 2025 -0.13
Feb 17, 2025 -0.62
Nov 07, 2024 -0.14
Aug 23, 2024 -0.20